PMID: 2502790Jan 1, 1989Paper

Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide

Psychopharmacology
F J Miñano, R D Myers

Abstract

Following the stereotaxic implantation of chronic cannulae for intracerebroventricular (ICV) infusion, rats were given an alcohol preference test to establish their preferred concentration in comparison with water. After alcohol was removed, 15 mg/kg cyanamide was then injected subcutaneously for 4 days in order to maximize volitional intake of single solutions of alcohol, which in these animals ranged from 7 to 15%. The L-dopa-decarboxylase inhibitor benserazide (Ro 4-4602) injected subcutaneously twice daily in doses of 50-100 mg/kg failed to alter the rats' alcohol consumption either in terms of g/kg or proportional values. However, when given ICV twice daily in concentrations of 10 ng-2.0 micrograms per 5.0 microliters volume, benserazide attenuated the rats' alcohol drinking significantly. This reduction occurred in a dose-dependent manner in terms of both absolute and proportional intakes of alcohol. Pre-treatment of the animals with 1.0 microgram benserazide given ICV, when alcohol was removed from the test situation, did not abolish the subsequent ingestion of alcohol but its peripheral administration (50 mg/kg) enhanced drinking. These results suggest that the interference with the metabolic pathway of dopamine or sero...Continue Reading

References

Sep 1, 1979·The Journal of Pharmacy and Pharmacology·T ErikssonA Carlsson
Jan 1, 1978·Annual Review of Pharmacology and Toxicology·R D Myers
Sep 1, 1978·Pharmacology, Biochemistry, and Behavior·F S Messiha
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·G Bartholini, A Pletscher
Apr 15, 1976·Experientia·K BlumH A Schwertner
Dec 15, 1976·Biochemical Pharmacology·R A DeitrichW S Worth
Jan 1, 1985·Psychopharmacology·J BalldinG Långström
Apr 1, 1987·Pharmacology, Biochemistry, and Behavior·H RommelspacherJ Weiss
Oct 1, 1987·Medical and Veterinary Entomology·P G JuppO W Prozesky
May 1, 1988·Pharmacology, Biochemistry, and Behavior·S A Signs, M D Schechter
Feb 1, 1988·Pharmacology, Biochemistry, and Behavior·A O Pfeffer, H H Samson
Sep 1, 1985·Alcohol·A O Pfeffer, H H Samson
May 1, 1969·The Journal of Pharmacy and Pharmacology·G Bartholini, A Pletscher
Feb 1, 1971·The British Journal of Venereal Diseases·R N ThinC S Nicol
Jun 1, 1981·Pharmacology, Biochemistry, and Behavior·D C KiktaJ E Greenleaf
Dec 1, 1981·Pharmacology, Biochemistry, and Behavior·I GellerF S Messiha
Mar 1, 1981·Pharmacology, Biochemistry, and Behavior·R M ThreatteD C Kikta
Jun 1, 1982·Pharmacology, Biochemistry, and Behavior·R D MyersW D Ruwe
Mar 1, 1981·Pharmacology, Biochemistry, and Behavior·J D Sinclair, K O Lindros
Jul 1, 1980·Journal of Neurochemistry·A ReggianiM Trabucchi

❮ Previous
Next ❯

Citations

Dec 1, 1991·Pharmacology, Biochemistry, and Behavior·R D Myers, S D Quarfordt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.